テキサスにおける肝硬変の臨床試験
テキサス内の拠点で、肝硬変に関する13件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Texas Clinical Research Institute, LLC, Arlington
- IMA Clinical Research Austin, Austin
- American Research Corporation - Austin, Austin
- 他35件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Texas Clinical Research Institute, LLC, Arlington
- Epic Medical Research - Carrollton, Carrollton
- The Liver Institute at Methodist Dallas, Dallas
- 他5件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT07325526National Liver Cancer Screening Trial
- UT Southwestern Medical Center and Parkland Hospital, Dallas
- Baylor College of Medicine, Houston
被験者募集中第4相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Austin
- Research Site, Denison
- Research Site, Georgetown
- 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT07610837Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/10更新 · NCT05181826Multi-analyte Blood Test Clinical Trial
- South Texas Research Institute, Edinburg
- Texas Gastro Research, El Paso
- Impact Research Institute, Waco
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/10更新 · NCT05199259High Dose Albumin in Refractory Ascites
- Baylor St' Lukes Medical center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/30更新 · NCT05867602Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
- UT Health San Antonio, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/01/06更新 · NCT06526104Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2025/10/20更新 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2025/09/23更新 · NCT05028829EGCG for Hepatocellular Carcinoma Chemoprevention
- UT Southwestern, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2025/09/05更新 · NCT06015022Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Methodist Health System, Dallas Medical Center, Dallas
- VA North Texas Healthcare System, Dallas
- Texas Liver Institute, San Antonio
被験者募集中第1相
18歳〜75歳 · 全性別 · 2025/09/05更新 · NCT05490888Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- First Surgical Hospital, Bellaire
- Endeavor Clinical Trials, San Antonio
被験者募集中観察研究
18歳〜75歳 · 全性別 · 2025/08/14更新 · NCT07122700ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。